HEXABRIX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hexabrix, and what generic alternatives are available?
Hexabrix is a drug marketed by Guerbet and is included in one NDA.
The generic ingredient in HEXABRIX is ioxaglate meglumine; ioxaglate sodium. Additional details are available on the ioxaglate meglumine; ioxaglate sodium profile page.
Summary for HEXABRIX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
Clinical Trials: | 2 |
Patent Applications: | 100 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HEXABRIX at DailyMed |
Recent Clinical Trials for HEXABRIX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Guerbet | Phase 4 |
NYU Langone Health | Phase 4 |
New York University School of Medicine | Phase 4 |
US Patents and Regulatory Information for HEXABRIX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HEXABRIX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for HEXABRIX
See the table below for patents covering HEXABRIX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
United Kingdom | 1488903 | ⤷ Try a Trial | |
Germany | 2524059 | ⤷ Try a Trial | |
Czechoslovakia | 207563 | METHOD OF MAKING THE DERIVATIVES OF THE ACID 2,4,6-TRIIOD-5/BIS/2,4,6-TRIIODPHENYL/-CARBOMOYLMETHYL/AMINOACETAMIDO/-BENZOO,UTILIZABLE AS CONTRAST SUBSTANCES IN RADIOGRAPHY | ⤷ Try a Trial |
Canada | 1086328 | SUBSTANCES DE CONTRASTE POUR RAYONS X (X-RAY CONTRAST MEDIA) | ⤷ Try a Trial |
Japan | S613779 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |